Literature DB >> 15218964

Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.

Silvana Capalbo1, Vincenzo Callea, Caterina Musolino, Patrizia Guglielmo, Giovanni D'Arena, Alberto Fragasso, Cosima Battista, Rosario Giustolisi, Maura Brugiatelli, Vincenzo Liso.   

Abstract

We investigated the prevalence of chronic lymphocytic leukemia (CLL) in 9650 relatives of 510 CLL patients from 5 different regions (Apulia, Basilicata, Campania, Calabria, and Sicily) of Southern Italy. Data collection included a family history questionnaire. In our series of 510 CLL patients, 53 families with 2 or more individuals who had chronic lymphoproliferative disease (CLD) or other hematological malignancies were identified. In these families, 27 cases of CLL, 10 of indolent non-Hodgkin's lymphoma, and 7 of multiple myeloma were identified in relatives of CLL probands. Twenty-two relatives developed hematological malignancies other than CLD (19, acute leukemia; 3, chronic myeloid leukemia). In this study the prevalence of CLD in relatives of 510 CLL patients was 8.6% (44/510), and the prevalence of CLL in the same series was 5.2% (27/ 510). Considering the presence of clusters of individuals with hematological malignancies, overall our series contained 4 families showing a cluster with more than 2 cases. The most frequent pattern of affected family members was represented by 39 families (39/53 [73%]) with affected siblings or cousins only. Twenty siblings had CLL. The other families showed a multigenerational pattern with an affected parent-offspring relationship in only 11 (21%) of the cases and with a combination of the first 2 categories in 3 (6%) of the families. In 8 families belonging to both the last 2 mentioned groups, the affected offspring had an earlier disease onset than their parents, suggesting anticipation. We estimated the size and examined the pattern of familial aggregation of hematological malignancies, in particular CLL/CLD, in a specific geographical area. CLL was the most frequent disease in relatives, mainly siblings, of our CLL patients. Our results may be a contribution to the characterization of the epidemiological distribution pattern of CLL.

Entities:  

Mesh:

Year:  2004        PMID: 15218964     DOI: 10.1532/ijh97.e0304

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  34 in total

1.  Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia.

Authors:  S Bevan; D Catovsky; A Marossy; E Matutes; S Popat; P Antonovic; A Bell; A Berrebi; E Gaminara; K Quabeck; I Ribeiro; F R Mauro; P Stark; H Sykes; J van Dongen; J Wimperis; S Wright; M R Yuille; R S Houlston
Journal:  Leukemia       Date:  1999-10       Impact factor: 11.528

2.  Analysis of expressed immunoglobulin heavy chain genes in familial B-CLL.

Authors:  A Sakai; G E Marti; N Caporaso; S Pittaluga; J W Touchman; F Fend; M Raffeld
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

Review 3.  Familial chronic lymphocytic leukaemia: a survey and review of published studies.

Authors:  M R Yuille; E Matutes; A Marossy; B Hilditch; D Catovsky; R S Houlston
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

4.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

5.  Preferred usage of specific immunoglobulin gene segments in chronic lymphocytic leukaemia cells of three HLA-identical sisters.

Authors:  I Hakim; N Amariglio; F Brok-Simoni; M Berkowitz; E Rosner; A Kneller; N Hulu; B Ramot; I Ben-Bassat; G J Silverman
Journal:  Br J Haematol       Date:  1995-12       Impact factor: 6.998

6.  Chronic lymphocytic leukemia (CLL) is rare, but the proportion of T-CLL is high in Japan.

Authors:  K Tamura; H Sawada; Y Izumi; T Fukuda; A Utsunomiya; S Ikeda; N Uike; J Tsukada; F Kawano; T Shibuya; H Gondo; S Okamura; J Suzumiya
Journal:  Eur J Haematol       Date:  2001-09       Impact factor: 2.997

7.  Increased incidence of hematologic malignancies in first-degree relatives of patients with chronic lymphocytic leukemia.

Authors:  J Cuttner
Journal:  Cancer Invest       Date:  1992       Impact factor: 2.176

8.  Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.

Authors:  S Capalbo; P Trerotoli; A Ciancio; C Battista; G Serio; V Liso
Journal:  Eur J Haematol       Date:  2000-08       Impact factor: 2.997

9.  Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Authors:  Andy C Rawstron; Martin R Yuille; Julie Fuller; Matthew Cullen; Ben Kennedy; Stephen J Richards; Andrew S Jack; Estella Matutes; Daniel Catovsky; Peter Hillmen; Richard S Houlston
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

10.  Chronic lymphocytic leukaemia: case control epidemiological study in Yorkshire.

Authors:  R A Cartwright; S M Bernard; C C Bird; C M Darwin; C O'Brien; I D Richards; B Roberts; P A McKinney
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

View more
  1 in total

Review 1.  Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study.

Authors:  Sylvia Hoeller; Yi Zhou; Rashmi Kanagal-Shamanna; Zijun Y Xu-Monette; Daniela Hoehn; Michel Bihl; Steven H Swerdlow; Andreas Rosenwald; German Ott; Jonathan Said; Cherie H Dunphy; Carlos E Bueso-Ramos; Pei Lin; Michael Wang; Roberto N Miranda; Alexander Tzankov; L Jeffrey Medeiros; Ken H Young
Journal:  Hum Pathol       Date:  2012-08-31       Impact factor: 3.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.